Sunitinib base - Bio-X ™

CAS: 557795-19-4

Ref. 3D-BD164426

Información del producto

• Nombre: Sunitinib base - Bio-X ™
• Sinónimos: N-(2-(-Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
• CAS: 557795-19-4

Descripción

Sunitinib is a tyrosine kinase inhibitor drug. It is a drug that is used as a treatment for renal cell carcinoma, gastrointestinal stromal tumor, and other solid tumors. This drug inhibits tyrosine kinases such as VEGFRs, this prevents tumour growth and pathologic angiogenesis.

Sunitinib base is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 398.47 g/mol
• Fórmula: C₂₂H₂₇FN₄O₂
• Pureza: Min. 95%
• Color/Forma: Powder
• InChI: InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-
• Clave InChI: InChIKey=WINHZLLDWRZWRT-ATVHPVEESA-N
• SMILES: CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C